NeetaSomaiahMD

PubMed

• Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liver.
  Ahmed Awad, Koustav Pal, Steven Yevich, Joshua D Kuban, Alda Tam, Bruno C Odisio, Sanjay Gupta, Peiman Habibollahi, Andrew J Bishop, Anthony Paul Conley, Neeta Somaiah...> ;Cancer. 2024 Apr 20
• Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
  Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, Heather Lin, Behrang Amini, Skye C Mayo, Dejka Araujo, Robert S Benjamin, Anthony P Conley, John A Livingsto...> ;Cancers. 2024 Feb 23
• Incomplete Carney Triad.
  Waguespack, S., Somaiah, N., Lee, J., Elsayes, K.> ;JCEM Case Reports. 2024 Feb 1
• 3 citations
  Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.
  Michael C Heinrich, Robin L Jones, Suzanne George, Hans Gelderblom, Patrick Schöffski, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonat...> ;Nature Medicine. 2024 Feb 1
• 1 citations
  MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of action.
  Somaiah, N., Tap, W.> ;Cancer Treatment Reviews. 2024 Jan 1
• 1 citations
  SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection.
  Ahsan S Farooqi, Alison K Yoder, Heather Y Lin, Dario Pasalic, Jeremy Erasmus, Sonia Betancourt, Cort Wernz, Devarati Mitra, Maria A Zarzour, Neeta Somaiah, Anthony Co...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Mar 15
• 2 citations
  Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors.
  César Serrano, Sara Rothschild, Guillermo Villacampa, Michael C Heinrich, Suzanne George, Jean-Yves Blay, Jason K Sicklick, Sameer Rastogi, Robin L Jones, Piotr Rutkow...> ;Nature Medicine. 2023 Nov 1
• 3 citations
  Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study.
  Hans Gelderblom, Robin L Jones, Jean-Yves Blay, Suzanne George, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonathan Trent, Steven Attia...> ;European Journal of Cancer. 2023 Oct 1
• A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor.
  Suzanne George, Michael C Heinrich, Neeta Somaiah, Peter Oppelt, Robert McLeod, Satoshi Nishioka, Madan G Kundu, Xiaozhong Qian, Prasanna Kumar, Abderrahmane Laadem, Y...> ;Clinical Cancer Research. 2023 Sep 15
• 2 citations
  Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).
  Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, Shiraj Sen, David S Hong, Aung Naing, Cynthia E Herzog, Siqing Fu, Sarina A Piha-Paul, Jordi Rodon, Timothy ...> ;Clinical Cancer Research. 2023 May 1
• Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.
  Blessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, Neeta Somaiah, Sarina Piha-Paul, Julia Ann Moore, Bulent Yilmaz, Deby Ogbonna, Daniel D Karp, Ecaterina Dumb...> ;Cancer. 2023 Jul 15
• 4 citations
  First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1).
  Sophie Postel-Vinay, Vincent K Lam, Willeke Ros, Todd M Bauer, Aaron R Hansen, Daniel C Cho, F Stephen Hodi, Jan H M Schellens, Jennifer K Litton, Sandrine Aspeslagh, ...> ;Journal for Immunotherapy of Cancer. 2023 Mar 1
• 2 citations
  Myxoid Liposarcomas: Systemic Treatment Options.
  Elise F Nassif, Emily Z Keung, Prapassorn Thirasastr, Neeta Somaiah> ;Current Treatment Options in Oncology. 2023 Apr 1
• Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.
  Tuyen Duong Thanh Nguyen, Yan Wang, Tuyen N Bui, Rossana Lazcano, Davis R Ingram, Min Yi, Varshini Vakulabharanam, Linjie Luo, Marc A Pina, Cansu Karakas, Mi Li, Nicol...> ;Cancer Research. 2023 Mar 15
• Case report: Responses to the combination of gemcitabine with sirolimus in two patients with-mutated sarcomas.
  Elise F Nassif, Cissimol P Joseph, Rossana Lazcano, Jocelyn T Joseph, Prapassorn Thirasastr, Alexander J Lazar, Neeta Somaiah> ;Frontiers in Oncology. 2023 Jan 1
• 1 citations
  Emerging Data on the Safety and Efficacy of Ripretinib for the Treatment of Gastrointestinal Stromal Tumors.
  Prapassorn Thirasastr, Neeta Somaiah> ;Clinical and Experimental Gastroenterology. 2023 Jan 1
• Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery.
  Mohamed A Gouda, Filip Janku, Neeta Somaiah, Kelly K Hunt, Sireesha Yedururi, Vivek Subbiah> ;Oncoscience. 2023 Jan 1
• 16 citations
  Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial.
  B Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, Ahsan Farooqi, Caroline Hempel, Courtney Dorber, Tiara Willis, Wei-Lien Wang, Ravin Ratan, Neeta Somaiah, Robe...> ;The Lancet. Oncology. 2022 Dec 1
• 4 citations
  Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102).
  Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, David S Hong, Aung Naing, Siqing Fu, Sarina Piha-Paul, Timothy A Yap, Daniel Karp, Jordi Rodon, Andy Livings...> ;Clinical Cancer Research. 2023 Jan 17
• 6 citations
  Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma.
  Andrew J Bishop, Behrang Amini, Heather Lin, Shaan M Raza, Shreyaskumar Patel, David R Grosshans, Amol Ghia, Ahsan Farooqi, B Ashleigh Guadagnolo, Devarati Mitra, Kadi...> ;Journal of Immunotherapy. 2022 Oct 1
• 2 citations
  Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma.
  Prapassorn Thirasastr, Heather Lin, Behrang Amini, Wei-Lien Wang, Jeffrey M Cloutier, Elise F Nassif, Emily Z Keung, Christina L Roland, Barry Feig, Dejka Araujo, Robe...> ;Cancer Medicine. 2023 Feb 1
• 7 citations
  OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.
  Julio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, Scott M Schuetze, Sujana Movva, Mark Agulnik, Andrew S Kraft, Eric D Tetzlaff, Neeta Somaiah, Margaret von Mehren> ;Cancer. 2022 Oct 1
• 45 citations
  Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.
  Neeta Somaiah, Anthony P Conley, Edwin Roger Parra, Heather Lin, Behrang Amini, Luisa Solis Soto, Ruth Salazar, Carmelia Barreto, Honglei Chen, Swati Gite, Cara Haymak...> ;The Lancet. Oncology. 2022 Sep 1
• 14 citations
  Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.
  Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, Sant Chawla, Javier Martin-Broto, Giovanni Grignani, Scott M Schuetze, Bruno Vincenzi, Andrew J Wagner, Bartosz ...> ;Journal of Clinical Oncology. 2022 Aug 1
• 8 citations
  Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.
  Vinod Ravi, Aparna Subramaniam, Jing Zheng, Behrang Amini, Van A Trinh, Jocelyn Joseph, Robert G Mennel, Andrew J Bishop, Erich M Sturgis, Ryan P Goepfert, Sudha Yalam...> ;Cancer. 2022 Sep 15
• Join now to see all

Journal Articles

• Characteristics and Outcomes of Patients with Advanced Sarcoma Enrolled in Early Phase Immunotherapy Trials  
  David S Hong, Neeta Somaiah, Anthony Conley, Shreyaskumar Patel, Filip Janku, Aung Naing, Kenneth Hess, Robert Benjamin, BioMed Central

Lectures

• Phase II trial of gemcitabine (G) with pazopanib (P) or gemcitabine with docetaxel (T) in advanced soft tissue sarcoma (STS). 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019